Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Buy
1,341
+76
+6% +$15.6K 0.07% 78
2026
Q1
$221K Sell
1,265
-275
-18% -$50.5K 0.06% 79
2025
Q4
$288K Sell
1,540
-323
-17% -$60.1K 0.09% 71
2025
Q3
$346K Sell
1,863
-210
-10% -$36.6K 0.11% 64
2025
Q2
$328K Buy
+2,073
New +$261K 0.11% 67
2025
Q1
Sell
-1,713
Closed -$230K 74
2024
Q4
$230K Sell
1,713
-449
-21% -$61.9K 0.07% 74
2024
Q3
$262K Buy
2,162
+2
+0.1% +$236 0.08% 73
2024
Q2
$267K Sell
2,160
-270
-11% -$27.3K 0.08% 73
2024
Q1
$220K Buy
+2,430
New +$176K 0.07% 71

Other funds holding NVDA

Hamel Associates's NVDA Position: Q2 2026 in Review

Hamel Associates increased its NVIDIA (NVDA) stake by 6% in Q2 2026, buying an estimated $15.6K and bringing the position to 1,341 shares worth $268K. The position accounts for 0.07% of the portfolio, ranked #78.

Hamel Associates first reported a position in NVDA in Q1 2024 and has held it in 9 quarters since. The position peaked at $346K in Q3 2025. 2,916 funds tracked by Wall St. Rank hold NVDA as of Q2 2026.

  • Hamel Associates held 1,341 shares of NVIDIA worth $268K as of Q2 2026.
  • Hamel Associates bought 76 NVIDIA shares in Q2 2026, an estimated $15.6K.
  • NVIDIA made up 0.07% of Hamel Associates's portfolio in Q2 2026, its #78 holding.
  • Hamel Associates first reported a position in NVIDIA in Q1 2024 and has held it in 9 quarters since.
  • Hamel Associates's NVIDIA position peaked at $346K in Q3 2025.
  • 2,916 funds tracked by Wall St. Rank held NVIDIA as of Q2 2026.

Based on Hamel Associates's 13F filing for Q2 2026, filed 27 Jul 2026.